Hartmut Schaefer
Bruker (United States)(US)Bruker (Germany)(DE)
Publications by Year
Research Areas
Metabolomics and Mass Spectrometry Studies, Long-Term Effects of COVID-19, Liver Disease Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments, Esophageal Cancer Research and Treatment
Most-Cited Works
- → Histomorphologic Tumor Regression and Lymph Node Metastases Determine Prognosis Following Neoadjuvant Radiochemotherapy for Esophageal Cancer(2005)370 cited
- → Response Evaluation by Endoscopy, Rebiopsy, and Endoscopic Ultrasound Does Not Accurately Predict Histopathologic Regression After Neoadjuvant Chemoradiation for Esophageal Cancer(2008)153 cited
- → THOMSEN FRIEDENREICH ANTIGEN IN HÆMOLYTIC-URÆMIC SYNDROME(1977)145 cited
- → Incomplete Systemic Recovery and Metabolic Phenoreversion in Post-Acute-Phase Nonhospitalized COVID-19 Patients: Implications for Assessment of Post-Acute COVID-19 Syndrome(2021)119 cited
- → High Specificity of Quantitative Excision Repair Cross-Complementing 1 Messenger RNA Expression for Prediction of Minor Histopathological Response to Neoadjuvant Radiochemotherapy in Esophageal Cancer(2004)109 cited